113 related articles for article (PubMed ID: 6376746)
41. AIDS-related complex treated by antiviral drugs and allogeneic bone marrow transplantation following conditioning protocol with busulphan, cyclophosphamide and cyclosporin.
Torlontano G; Di Bartolomeo P; Di Girolamo G; Angrilli F; Verani P; Maggiorella MT; Dragani A; Iacone A; Papalinetti G; Olioso P
Haematologica; 1992; 77(3):287-90. PubMed ID: 1427437
[TBL] [Abstract][Full Text] [Related]
42. Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
Topolsky D; Crilley P; Styler MJ; Bulova S; Brodsky I; Marks DI
Bone Marrow Transplant; 1996 Apr; 17(4):549-54. PubMed ID: 8722353
[TBL] [Abstract][Full Text] [Related]
43. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272
[TBL] [Abstract][Full Text] [Related]
44. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
[TBL] [Abstract][Full Text] [Related]
45. Busulphan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in fifty children.
Shaw PJ; Hugh-Jones K; Hobbs JR; Downie CJ; Barnes R
Bone Marrow Transplant; 1986 Dec; 1(2):193-200. PubMed ID: 3332132
[TBL] [Abstract][Full Text] [Related]
46. Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy.
Van der Jagt RH; Appelbaum FR; Petersen FB; Bigelow CL; Fisher LD; Schoch GH; Buckner CD; Sanders JE; Storb R; Sullivan KM
Bone Marrow Transplant; 1991 Sep; 8(3):211-5. PubMed ID: 1958901
[TBL] [Abstract][Full Text] [Related]
47. CD40 ligand deficiency with grade III liver fibrosis, transplanted by a treosulphan-based conditioning regimen.
Dogu F; Cipe FE; Reisli I; Erden E; Ikinciogullari A
Exp Clin Transplant; 2011 Oct; 9(5):349-52. PubMed ID: 21967264
[TBL] [Abstract][Full Text] [Related]
48. Busulfan/cyclophosphamide plus bone marrow transplantation is not sufficient to eradicate the malignant clone in juvenile chronic myelogenous leukemia.
Urban C; Schwinger W; Slavc I; Schmid C; Gamillscheg A; Lackner H; Hauer C; Pakisch B
Bone Marrow Transplant; 1990 May; 5(5):353-6. PubMed ID: 2190661
[TBL] [Abstract][Full Text] [Related]
49. Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome.
Ozkaynak MF; Weinberg K; Kohn D; Sender L; Parkman R; Lenarsky C
Bone Marrow Transplant; 1991 Jun; 7(6):467-74. PubMed ID: 1908340
[TBL] [Abstract][Full Text] [Related]
50. Busulfan (Bu) and cyclophosphamide (Cy) for marrow transplantation.
Santos GW
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():236-9. PubMed ID: 2653511
[TBL] [Abstract][Full Text] [Related]
51. Allogeneic bone marrow transplantation for fucosidosis.
Vellodi A; Cragg H; Winchester B; Young E; Young J; Downie CJ; Hoare RD; Stocks R; Banerjee GK
Bone Marrow Transplant; 1995 Jan; 15(1):153-8. PubMed ID: 7742750
[TBL] [Abstract][Full Text] [Related]
52. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.
Klein JL; Avalos BR; Belt P; Taylor CA; Ezzone SA; Scholl MD; Fisher J; Young D; Copelan EA
Bone Marrow Transplant; 1996 Apr; 17(4):479-83. PubMed ID: 8722342
[TBL] [Abstract][Full Text] [Related]
53. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
[TBL] [Abstract][Full Text] [Related]
54. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
[TBL] [Abstract][Full Text] [Related]
55. Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.
Bielorai B; Toren A; Wolach B; Mandel M; Golan H; Neumann Y; Kaplinisky C; Weintraub M; Keller N; Amariglio N; Paswell J; Rechavi G
Bone Marrow Transplant; 2000 Nov; 26(9):1025-8. PubMed ID: 11100285
[TBL] [Abstract][Full Text] [Related]
56. Kinetics of destruction and regeneration of the haemopoietic system after administration of busulphan and cyclophosphamide followed by bone marrow transplantation. Peripheral blood parameters.
Szczylik C; Ratajczak MZ; Urbanowska E; Jedrzejczak WW
Acta Med Pol; 1989; 30(3-4):93-109. PubMed ID: 2519630
[TBL] [Abstract][Full Text] [Related]
57. Successful unrelated bone marrow transplantation in a child with chronic granulomatous disease complicated by pulmonary and cerebral granuloma formation.
Schuetz C; Hoenig M; Schulz A; Lee-Kirsch MA; Roesler J; Friedrich W; von Bernuth H
Eur J Pediatr; 2007 Aug; 166(8):785-8. PubMed ID: 17103189
[TBL] [Abstract][Full Text] [Related]
58. Improved results of allogeneic bone marrow transplantation for advanced hematologic malignancy using busulfan, cyclophosphamide and etoposide as cytoreductive and immunosuppressive therapy.
Vaughan WP; Dennison JD; Reed EC; Klassen L; McGuire TR; Sanger WG; Kumar PP; Warkentin PI; Gordon BG; Bierman PJ
Bone Marrow Transplant; 1991 Dec; 8(6):489-95. PubMed ID: 1790429
[TBL] [Abstract][Full Text] [Related]
59. Successful unrelated bone marrow transplantation in beta-thalassaemia.
Contu L; La Nasa G; Arras M; Ledda A; Pizzati A; Vacca A; Carcassi C; Floris L; Porcella R; Orrù S
Bone Marrow Transplant; 1994 Mar; 13(3):329-31. PubMed ID: 8199574
[TBL] [Abstract][Full Text] [Related]
60. Fatal cyclophosphamide-induced congestive heart failure in a 10-year-old boy with Shwachman-Diamond syndrome and severe bone marrow failure treated with allogeneic bone marrow transplantation.
Tsai PH; Sahdev I; Herry A; Lipton JM
Am J Pediatr Hematol Oncol; 1990; 12(4):472-6. PubMed ID: 2285129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
